Study on Hypoallergenic Hair Dye

Status Completed

Clinical Trial Summary

Permanent hair dyes are commonly used in over the counter direct to consumer products and within hair salons. Allergy, also known as contact dermatitis, to hair dye is a well known phenomenon. Herein, we seek to decrease the risks of allergy to hair dyes by testing a novel version of p-phenylenediamine (PPD) with less allergy potential.

Clinical Trial Description

For patients with PPD sensitizations, it is important to find alternatives for dark hair dyes. P-toluenediamine (PTD) and potentially also 2-methoxyethyl p-phenylenediamine (ME-PPD) show cross-reactivity with PPD and therefore we want to prove that our new compounds PPD-6 and PPD-7 show no or significantly reduced cross-reactions with PPD and do not induce relevant allergic reactions in patients with proven PPD sensitizations. Our specific aims for this study are the following: A1) To show that PPD 6 and PPD 7 have reduced or optimally no reaction in standard patch tests in patients with proven allergy to PPD A2) To compare the sensitization pattern to other possible commercially available alternatives for hair dye, such as ME-PPD and PTD A3) To evaluate and rule out any possible non-specific irritant reaction of PPD-6 and PPD-7 in these patch tests (i.e. confirm in-vitro safety profile in-vivo) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04772482
Study type	Observational
Source	University of Minnesota
Contact
Status	Completed
Phase
Start date	April 1, 2021
Completion date	May 13, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Recruiting	`NCT01631617` - Effects of Treatments on Atopic Dermatitis	Phase 2
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Recruiting	`NCT01012453` - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema	N/A
Completed	`NCT00375713` - Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema	Phase 3
Completed	`NCT00001150` - Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers	N/A
Completed	`NCT05247333` - Implementation of a Minor Ailment Service in Community Pharmacy Practice	N/A
Withdrawn	`NCT04154033` - Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone	Phase 2
Completed	`NCT02979210` - Infant Fecal Insult Study	N/A
Completed	`NCT02615912` - A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants	N/A
Withdrawn	`NCT01125761` - Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis	Phase 3
Withdrawn	`NCT00746382` - A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)	Phase 2
Terminated	`NCT00176956` - Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients	Phase 3
Completed	`NCT05001139` - Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam	N/A
Completed	`NCT00801502` - Salmon in Pregnancy Study	N/A
Completed	`NCT00005781` - Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles	N/A
Completed	`NCT05324618` - Tacrolimus Versus Hydrocortisone in Atopic Dermatitis	Phase 4
Completed	`NCT04826471` - Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam	N/A
Recruiting	`NCT06436183` - A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis	Phase 2